Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Almac Group Ltd.
DescriptionSubtype selective Akt1 & Akt2 inhibitor
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA) ; Protein kinase B beta (AKT2) (PKBB)
Mechanism of ActionProtein kinase B (PKB) (AKT1) inhibitor; Protein kinase B beta (PKBB) (AKT2) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today